BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30694510)

  • 1. Revisiting the Significance of Prominent C Cells in the Thyroid.
    Fuchs TL; Bell SE; Chou A; Gill AJ
    Endocr Pathol; 2019 Jun; 30(2):113-117. PubMed ID: 30694510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
    Perry A; Molberg K; Albores-Saavedra J
    Cancer; 1996 Feb; 77(4):750-6. PubMed ID: 8616768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
    Baloch ZW; LiVolsi VA
    Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
    Raue F; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial medullary thyroid carcinoma: case report and literature review.].
    Barletta Carrillo CF; Poterico Rojas JA; Barrionuevo Cornejo C; Casavilca Zambrano S; Pinedo Cárdenas A; Quispe Santibañez I; Castro Mujica MDC
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):303-309. PubMed ID: 30734711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.
    Essig GF; Porter K; Schneider D; Arpaia D; Lindsey SC; Busonero G; Fineberg D; Fruci B; Boelaert K; Smit JW; Meijer JA; Duntas LH; Sharma N; Costante G; Filetti S; Sippel RS; Biondi B; Topliss DJ; Pacini F; Maciel RM; Walz PC; Kloos RT
    Thyroid; 2016 Nov; 26(11):1563-1572. PubMed ID: 27604949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid cancer.
    Moley JF
    Surg Clin North Am; 1995 Jun; 75(3):405-20. PubMed ID: 7747249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid.
    Scognamiglio T
    Arch Pathol Lab Med; 2017 Dec; 141(12):1646-1652. PubMed ID: 28644684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
    Ting S; Synoracki S; Schmid KW
    Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases.
    Etit D; Faquin WC; Gaz R; Randolph G; DeLellis RA; Pilch BZ
    Arch Pathol Lab Med; 2008 Nov; 132(11):1767-73. PubMed ID: 18976013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma.
    Yadav M; Agrawal V; Pani KC; Verma R; Jaiswal S; Mishra A; Pandey R
    Indian J Pathol Microbiol; 2018; 61(4):485-488. PubMed ID: 30303134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Hereditary Medullary Thyroid Cancer (MEN2A/FMTC) Diagnosed at the Time of Recurrence].
    Enomoto K; Shimizu K; Hirose M; Miyabe H; Morizane N; Takenaka Y; Shimazu K; Fushimi H; Uno A
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Mar; 118(3):219-23. PubMed ID: 26349338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathology of preclinical medullary thyroid carcinoma.
    Ashworth M
    Endocr Pathol; 2004; 15(3):227-31. PubMed ID: 15640548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-cell hyperplasia and medullary thyroid microcarcinoma.
    Albores-Saavedra JA; Krueger JE
    Endocr Pathol; 2001; 12(4):365-77. PubMed ID: 11914470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.